相似文献
1
Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs.
Cell Mol Neurobiol. 1999 Aug;19(4):491-510. doi: 10.1023/a:1006938908284.
2
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Mol Psychiatry. 2007 Aug;12(8):707-47. doi: 10.1038/sj.mp.4002009. Epub 2007 Jun 5.
3
Pharmacogenetics and psychopharmacotherapy.
J Clin Pharm Ther. 2000 Jun;25(3):197-220. doi: 10.1046/j.1365-2710.2000.00281.x.
4
Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
Clin Pharmacokinet. 2002;41(7):453-70. doi: 10.2165/00003088-200241070-00001.
5
Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions.
Curr Drug Metab. 2008 Jun;9(5):410-8. doi: 10.2174/138920008784746373.
6
Pharmacogenetics of classical and new antipsychotic drugs.
Ther Drug Monit. 2000 Feb;22(1):118-21. doi: 10.1097/00007691-200002000-00025.
7
Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
Psychiatr Danub. 2010 Jun;22(2):335-7.
8
Cytochrome P450 polymorphisms and response to antipsychotic therapy.
Pharmacogenomics. 2002 Mar;3(2):201-18. doi: 10.1517/14622416.3.2.201.
9
In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Pharmacol Rep. 2020 Jun;72(3):612-621. doi: 10.1007/s43440-020-00089-z. Epub 2020 Mar 26.
10
Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: clinical and interethnic aspects.
Clin Pharmacol Ther. 2007 Nov;82(5):606-9. doi: 10.1038/sj.clpt.6100358. Epub 2007 Sep 26.
引用本文的文献
1
Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation.
Front Cardiovasc Med. 2022 Feb 21;9:839104. doi: 10.3389/fcvm.2022.839104. eCollection 2022.
2
Cardio-oncology/onco-cardiology.
Clin Cardiol. 2010 Dec;33(12):733-7. doi: 10.1002/clc.20823.
3
Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.
Clin Pharmacokinet. 2004;43(1):33-56. doi: 10.2165/00003088-200443010-00003.
4
Drug-metabolizing cytochrome P450s in the brain.
J Psychiatry Neurosci. 2002 Nov;27(6):406-15.
5
High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies.
Genome Res. 2000 Aug;10(8):1219-29. doi: 10.1101/gr.10.8.1219.
6
Biotransformation of post-clozapine antipsychotics: pharmacological implications.
Clin Pharmacokinet. 2000 May;38(5):393-414. doi: 10.2165/00003088-200038050-00002.
本文引用的文献
1
ELECTRON-PARAMAGNETIC-RESONANCE STUDIES OF THE CHLORPROMAZINE FREE RADICAL FORMED DURING ENZYMIC OXIDATION BY PEROXIDASE-HYDROGEN PEROXIDE.
Biochim Biophys Acta. 1964 Jul 29;88:120-9. doi: 10.1016/0926-6577(64)90160-3.
2
Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine.
Chem Biol Interact. 1999 Apr 1;118(2):171-89. doi: 10.1016/s0009-2797(99)00006-x.
3
Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine.
Naunyn Schmiedebergs Arch Pharmacol. 1998 Nov;358(5):592-9. doi: 10.1007/pl00005298.
4
Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
J Clin Psychopharmacol. 1998 Feb;18(1):2-9. doi: 10.1097/00004714-199802000-00002.
5
Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
Clin Pharmacokinet. 1997 Dec;33(6):454-71. doi: 10.2165/00003088-199733060-00004.
6
Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol.
Br J Clin Pharmacol. 1997 Dec;44(6):557-64. doi: 10.1046/j.1365-2125.1997.t01-1-00629.x.
7
Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes.
Drug Metab Dispos. 1997 Dec;25(12):1379-82.
8
The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine.
Br J Clin Pharmacol. 1997 Nov;44(5):439-46. doi: 10.1046/j.1365-2125.1997.t01-1-00605.x.
9
Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivo.
Clin Pharmacol Ther. 1997 Sep;62(3):334-47. doi: 10.1016/S0009-9236(97)90037-0.
10
Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol.
Cell Mol Neurobiol. 1997 Apr;17(2):227-33. doi: 10.1023/a:1026317929335.
Zotero 插件